Top Clinical Trials companies in United Kingdom by Operating Income Margin

This ranking features the top 12 Clinical Trials companies in United Kingdom ranked by Operating Income Margin, averaging a Operating Income Margin of -2,248.64%, for January 15, 2025.
#
Name
Operating Income Margin
Reported Date
Stock Price
Change
Price (30 days) Country
1
18.03%
Dec. 31, 2023 USD 0.21 6.16%

United Kingdom

2
-23.91%
Dec. 31, 2023 USD 28.56 -4.90%

United Kingdom

3
-24.45%
Dec. 31, 2023 USD 0.49 0.09%

United Kingdom

4
-114.93%
Dec. 31, 2023 USD 0.62 -2.80%

United Kingdom

5
-195.48%
Dec. 31, 2023 USD 5.61 -4.92%

United Kingdom

6
-284.16%
Dec. 31, 2023 USD 3.06 -8.38%

United Kingdom

7
-331.06%
Dec. 31, 2023 USD 0.04 0.09%

United Kingdom

8
-704.13%
Dec. 31, 2023 USD 14.81 -2.31%

United Kingdom

9
-875.32%
Dec. 31, 2023 USD 0.05 -16.59%

United Kingdom

10
-2,499.39%
Dec. 31, 2023 USD 14.84 -2.75%

United Kingdom

11
-10,463.09%
Dec. 31, 2023 USD 0.95 0.80%

United Kingdom

12
-11,485.75%
Dec. 31, 2023 USD 2.21 -3.91%

United Kingdom

Frequently Asked Questions
  • Which Clinical Trials company in United Kingdom has the highest Operating Income Margin ?

    The Clinical Trials company in United Kingdom with the highest Operating Income Margin is hVIVO plc (LSE: HVO.L) at 18.03%.

  • Which Clinical Trials company in United Kingdom has the lowest Operating Income Margin ?

    The Clinical Trials company in United Kingdom with the lowest Operating Income Margin is Autolus Therapeutics plc (NasdaqGS: AUTL) at -11,485.75%.